Stocks and Investing
Stocks and Investing
Thu, May 24, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, May 23, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Oren Livnat Maintained (CARA) at Strong Buy with Increased Target to $24 on, May 23rd, 2018
Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $22 to $24 on, May 23rd, 2018.
Oren has made no other calls on CARA in the last 4 months.
There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Ken Trbovich of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Monday, February 12th, 2018